| Year |
Citation |
Score |
| 2023 |
Meng H, Sengupta A, Ricciotti E, Mrčela A, Mathew D, Mazaleuskaya LL, Ghosh S, Brooks TG, Turner AP, Schanoski AS, Lahens NF, Tan AW, Woolfork A, Grant G, Susztak K, ... ... FitzGerald GA, et al. Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsis. Clinical and Translational Medicine. 13: e1440. PMID 37948331 DOI: 10.1002/ctm2.1440 |
0.519 |
|
| 2023 |
Meng H, Sengupta A, Ricciotti E, Mrčela A, Mathew D, Mazaleuskaya LL, Ghosh S, Brooks TG, Turner AP, Schanoski AS, Lahens NF, Tan AW, Woolfork A, Grant G, Susztak K, ... ... FitzGerald GA, et al. Deep Phenotyping of the Lipidomic Response in COVID and non-COVID Sepsis. Biorxiv : the Preprint Server For Biology. PMID 37398323 DOI: 10.1101/2023.06.02.543298 |
0.553 |
|
| 2023 |
Anderson ST, Meng H, Brooks TG, Tang SY, Lordan R, Sengupta A, Nayak S, Mřela A, Sarantopoulou D, Lahens NF, Weljie A, Grant GR, Bushman FD, FitzGerald GA. Sexual dimorphism in the response to chronic circadian misalignment on a high-fat diet. Science Translational Medicine. 15: eabo2022. PMID 37196066 DOI: 10.1126/scitranslmed.abo2022 |
0.54 |
|
| 2023 |
Skarke C, Lordan R, Barekat K, Naik A, Mathew D, Ohtani T, Greenplate AR, Grant GR, Lahens NF, Gouma S, Troisi E, Sengupta A, Weljie AM, Meng W, Luning Prak ET, ... ... FitzGerald GA, et al. . The Journal of Pharmacology and Experimental Therapeutics. PMID 37105582 DOI: 10.1124/jpet.122.001415 |
0.528 |
|
| 2021 |
Lordan R, Prior S, Hennessy E, Naik A, Ghosh S, Paschos GK, Skarke C, Barekat K, Hollingsworth T, Juska S, Mazaleuskaya LL, Teegarden S, Glascock AL, Anderson S, Meng H, ... ... FitzGerald GA, et al. Considerations for the Safe Operation of Schools During the Coronavirus Pandemic. Frontiers in Public Health. 9: 751451. PMID 34976917 DOI: 10.3389/fpubh.2021.751451 |
0.512 |
|
| 2020 |
Yang G, Zhang J, Jiang T, Monslow J, Yew Tang S, Todd L, Puré E, Chen L, FitzGerald GA. Bmal1 (Brain and Muscle Aryl Hydrocarbon Receptor Nuclear-Like 1) Deletion in Myeloid Cells Attenuates Atherosclerotic Lesion Development and Restrains Abdominal Aortic Aneurysm Formation in Hyperlipidemic Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314318. PMID 32321308 DOI: 10.1161/Atvbaha.120.314318 |
0.309 |
|
| 2019 |
Ruben MD, Smith DF, FitzGerald GA, Hogenesch JB. Dosing time matters. Science (New York, N.Y.). 365: 547-549. PMID 31395773 DOI: 10.1126/Science.Aax7621 |
0.499 |
|
| 2019 |
Sacco A, Bruno A, Contursi A, Dovizio M, Tacconelli S, Ricciotti E, Guillem-Llobat P, Salvatore T, Di Francesco L, Fullone R, Ballerini P, Arena V, Alberti S, Liu G, Gong Y, ... ... FitzGerald G, et al. Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 31248980 DOI: 10.1124/Jpet.119.259382 |
0.323 |
|
| 2018 |
Chen L, Yang G, Zhang J, Ren B, Tang S, Li X, FitzGerald GA. Time-Dependent Hypotensive Effect of Aspirin in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 38: 2819-2826. PMID 30571171 DOI: 10.1161/Atvbaha.118.311296 |
0.333 |
|
| 2018 |
Elling R, Robinson EK, Shapleigh B, Liapis SC, Covarrubias S, Katzman S, Groff AF, Jiang Z, Agarwal S, Motwani M, Chan J, Sharma S, Hennessy EJ, FitzGerald GA, McManus MT, et al. Genetic Models Reveal cis and trans Immune-Regulatory Activities for lincRNA-Cox2. Cell Reports. 25: 1511-1524.e6. PMID 30404006 DOI: 10.1016/J.Celrep.2018.10.027 |
0.301 |
|
| 2018 |
Ricciotti E, Castro C, Tang SY, Briggs WTE, West JA, Malik D, Rhoades SD, Meng H, Li X, Lahens NF, Sparks JA, Karlson EW, Weljie AM, Griffin JL, FitzGerald GA. Cyclooxygenase-2, Asymmetric Dimethylarginine and the Cardiovascular Hazard from NSAIDs. Circulation. PMID 29930022 DOI: 10.1161/Circulationaha.118.033540 |
0.609 |
|
| 2018 |
Ocana JA, Romer E, Sahu R, Pawelzik SC, FitzGerald GA, Kaplan MH, Travers JB. Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms. Journal of Immunology (Baltimore, Md. : 1950). PMID 29695417 DOI: 10.4049/Jimmunol.1701145 |
0.315 |
|
| 2017 |
Skarke C, Lahens NF, Rhoades SD, Campbell A, Bittinger K, Bailey A, Hoffmann C, Olson RS, Chen L, Yang G, Price TS, Moore JH, Bushman FD, Greene CS, Grant GR, ... ... FitzGerald GA, et al. A Pilot Characterization of the Human Chronobiome. Scientific Reports. 7: 17141. PMID 29215023 DOI: 10.1038/S41598-017-17362-6 |
0.727 |
|
| 2017 |
Li X, Mazaleuskaya LL, Yuan C, Ballantyne LL, Meng H, Smith WL, FitzGerald GA, Funk CD. Flipping the Cyclooxygenase (Ptgs) Genes Reveals Isoform-Specific Compensatory Functions. Journal of Lipid Research. PMID 29180445 DOI: 10.1194/Jlr.M079996 |
0.333 |
|
| 2017 |
Li X, Mazaleuskaya LL, Ballantyne LL, Meng H, FitzGerald GA, Funk CD. Genomic and lipidomic analyses differentiate the compensatory roles of two cyclooxygenase isoforms during systemic inflammation in mice. Journal of Lipid Research. PMID 29180443 DOI: 10.1194/Jlr.M080028 |
0.317 |
|
| 2017 |
Hughes ME, Abruzzi KC, Allada R, Anafi R, Arpat AB, Asher G, Baldi P, de Bekker C, Bell-Pedersen D, Blau J, Brown S, Ceriani MF, Chen Z, Chiu JC, Cox J, ... ... FitzGerald GA, et al. Guidelines for Genome-Scale Analysis of Biological Rhythms. Journal of Biological Rhythms. 748730417728663. PMID 29098954 DOI: 10.1177/0748730417728663 |
0.528 |
|
| 2016 |
FitzGerald GA. ImPRECISION: Limitations to Interpretation of a Large Randomized Clinical Trial. Circulation. PMID 27840335 DOI: 10.1161/Circulationaha.116.026324 |
0.302 |
|
| 2016 |
Tang SY, Monslow J, Grant GR, Todd L, Pawelzik SC, Chen L, Lawson J, Puré E, FitzGerald GA. Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1 Deficient Hyperlipidemic Mice. Circulation. PMID 27440004 DOI: 10.1161/Circulationaha.116.022308 |
0.312 |
|
| 2016 |
Guillem-Llobat P, Dovizio M, Bruno A, Ricciotti E, Cufino V, Sacco A, Grande R, Alberti S, Arena V, Cirillo M, Patrono C, FitzGerald GA, Steinhilber D, Sgambato A, Patrignani P. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget. PMID 27074574 DOI: 10.18632/Oncotarget.8655 |
0.307 |
|
| 2016 |
Kim EJ, Lahens N, Ricciotti E, Manduchi E, Grosser T, Fitzgerald G, Hogenesch J, Grant G. Resampling-based read-level normalization of RNA-Seq for differential expression analysis F1000research. 5. DOI: 10.7490/F1000Research.1112772.1 |
0.504 |
|
| 2015 |
Fitzgerald GA, Yang G, Paschos GK, Liang X, Skarke C. Molecular clocks and the human condition: approaching their characterization in human physiology and disease. Diabetes, Obesity & Metabolism. 17: 139-42. PMID 26332979 DOI: 10.1111/Dom.12526 |
0.302 |
|
| 2015 |
Markosyan N, Rech A, Vonderheide RH, FitzGerald GA, Smyth EM. Abstract 469: mPGES1 deletion and the mechanisms of tumor growth suppression Cancer Research. 75: 469-469. DOI: 10.1158/1538-7445.Am2015-469 |
0.569 |
|
| 2014 |
Li X, Fries S, Li R, Lawson JA, Propert KJ, Diamond SL, Blair IA, FitzGerald GA, Grosser T. Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proceedings of the National Academy of Sciences of the United States of America. 111: 16830-5. PMID 25385584 DOI: 10.1073/Pnas.1406997111 |
0.302 |
|
| 2014 |
Chen L, Yang G, Monslow J, Todd L, Cormode DP, Tang J, Grant GR, DeLong JH, Tang SY, Lawson JA, Pure E, Fitzgerald GA. Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America. 111: 6828-33. PMID 24753592 DOI: 10.1073/Pnas.1401797111 |
0.311 |
|
| 2014 |
Chen EP, Markosyan N, Connolly E, Lawson JA, Li X, Grant GR, Grosser T, FitzGerald GA, Smyth EM. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function. Carcinogenesis. 35: 1788-97. PMID 24590894 DOI: 10.1093/Carcin/Bgu053 |
0.672 |
|
| 2014 |
Tragante V, Barnes MR, Ganesh SK, Lanktree MB, Guo W, Franceschini N, Smith EN, Johnson T, Holmes MV, Padmanabhan S, Karczewski KJ, Almoguera B, Barnard J, Baumert J, Chang YP, ... ... FitzGerald GA, et al. Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. American Journal of Human Genetics. 94: 349-60. PMID 24560520 DOI: 10.1016/J.Ajhg.2013.12.016 |
0.61 |
|
| 2014 |
Tang SY, Monslow J, Todd L, Lawson J, Puré E, FitzGerald GA. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice. Circulation. 129: 1761-9. PMID 24519928 DOI: 10.1161/Circulationaha.113.007913 |
0.311 |
|
| 2014 |
Holmes MV, Lange LA, Palmer T, Lanktree MB, North KE, Almoguera B, Buxbaum S, Chandrupatla HR, Elbers CC, Guo Y, Hoogeveen RC, Li J, Li YR, Swerdlow DI, Cushman M, ... ... FitzGerald GA, et al. Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. American Journal of Human Genetics. 94: 198-208. PMID 24462370 DOI: 10.1016/J.Ajhg.2013.12.014 |
0.593 |
|
| 2014 |
Holmes M, Lange L, Palmer T, Lanktree M, North K, Almoguera B, Buxbaum S, Chandrupatla H, Elbers C, Guo Y, Hoogeveen R, Li J, Li Y, Swerdlow D, Cushman M, ... ... FitzGerald G, et al. Causal Effects of Body Mass Index on Cardiometabolic Traits and Events: A Mendelian Randomization Analysis The American Journal of Human Genetics. 94: 312. DOI: 10.1016/J.Ajhg.2014.01.012 |
0.578 |
|
| 2013 |
Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, Roh JH, Ortiz-Gonzalez X, Dearborn JT, Culver JP, Herzog ED, Hogenesch JB, Wozniak DF, Dikranian K, Giasson BI, ... ... Fitzgerald GA, et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. The Journal of Clinical Investigation. 123: 5389-400. PMID 24270424 DOI: 10.1172/Jci70317 |
0.545 |
|
| 2013 |
Curtis AM, FitzGerald GA. Platelet microRNAs: Novy Mir* or mired in human complexity? Circulation Research. 112: 576-8. PMID 23410874 DOI: 10.1161/Circresaha.113.300859 |
0.319 |
|
| 2013 |
Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN, Johnson T, Castillo BA, Barnard J, Baumert J, Chang YP, Elbers CC, Farrall M, Fischer ME, Franceschini N, ... ... Fitzgerald GA, et al. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Human Molecular Genetics. 22: 1663-78. PMID 23303523 DOI: 10.1093/Hmg/Dds555 |
0.603 |
|
| 2013 |
Yu Z, Ricciotti E, Miwa T, Liu S, Ihida-Stansbury K, Landersberg G, Jones PL, Scalia R, Song WC, Assoian RK, FitzGerald GA. Myeloid cell 5-lipoxygenase activating protein modulates the response to vascular injury. Circulation Research. 112: 432-40. PMID 23250985 DOI: 10.1161/Circresaha.112.300755 |
0.474 |
|
| 2012 |
Yang G, FitzGerald GA. (Almost) everything is illuminated: adenosine shines a light on cardioprotection. Circulation Research. 111: 965-6. PMID 23023508 DOI: 10.1161/Circresaha.112.279752 |
0.303 |
|
| 2012 |
Yu Y, Ricciotti E, Scalia R, Tang SY, Grant G, Yu Z, Landesberg G, Crichton I, Wu W, Puré E, Funk CD, FitzGerald GA. Vascular COX-2 modulates blood pressure and thrombosis in mice. Science Translational Medicine. 4: 132ra54. PMID 22553252 DOI: 10.1126/Scitranslmed.3003787 |
0.524 |
|
| 2012 |
Yu Z, Crichton I, Tang SY, Hui Y, Ricciotti E, Levin MD, Lawson JA, Puré E, FitzGerald GA. Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice. Proceedings of the National Academy of Sciences of the United States of America. 109: 6727-32. PMID 22493243 DOI: 10.1073/Pnas.1115313109 |
0.51 |
|
| 2012 |
Song WL, Stubbe J, Ricciotti E, Alamuddin N, Ibrahim S, Crichton I, Prempeh M, Lawson JA, Wilensky RL, Rasmussen LM, Puré E, FitzGerald GA. Niacin and biosynthesis of PGD₂by platelet COX-1 in mice and humans. The Journal of Clinical Investigation. 122: 1459-68. PMID 22406532 DOI: 10.1172/Jci59262 |
0.343 |
|
| 2012 |
Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL, Lanktree MB, Tare A, Castillo BA, Li YR, Johnson T, Bruinenberg M, Gilbert-Diamond D, Rajagopalan R, Voight BF, ... ... FitzGerald GA, et al. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. American Journal of Human Genetics. 90: 410-25. PMID 22325160 DOI: 10.1016/J.Ajhg.2011.12.022 |
0.595 |
|
| 2012 |
Skarke C, Alamuddin N, Lawson JA, Cen L, Propert KJ, Fitzgerald GA. Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clinical Pharmacology and Therapeutics. 91: 986-93. PMID 22278334 DOI: 10.1038/Clpt.2012.3 |
0.306 |
|
| 2012 |
Dovizio M, Tacconelli S, Ricciotti E, Bruno A, Maier TJ, Anzellotti P, Di Francesco L, Sala P, Signoroni S, Bertario L, Dixon DA, Lawson JA, Steinhilber D, FitzGerald GA, Patrignani P. Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis. The Journal of Pharmacology and Experimental Therapeutics. 341: 242-50. PMID 22262921 DOI: 10.1124/Jpet.111.190785 |
0.326 |
|
| 2012 |
Lanktree M, Guo Y, Murtaza M, Glessner J, Bailey S, Onland-Moret N, Lettre G, Ongen H, Rajagopalan R, Johnson T, Shen H, Nelson C, Klopp N, Baumert J, Padmanabhan S, ... ... FitzGerald G, et al. Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height The American Journal of Human Genetics. 90: 1116-1117. DOI: 10.1016/J.Ajhg.2012.05.017 |
0.576 |
|
| 2012 |
Saxena R, Elbers C, Guo Y, Peter I, Gaunt T, Mega J, Lanktree M, Tare A, Castillo B, Li Y, Johnson T, Bruinenberg M, Gilbert-Diamond D, Rajagopalan R, Voight B, ... ... FitzGerald G, et al. Large-Scale Gene-Centric Meta-Analysis across 39 Studies Identifies Type 2 Diabetes Loci The American Journal of Human Genetics. 90: 753. DOI: 10.1016/J.Ajhg.2012.03.001 |
0.578 |
|
| 2011 |
Markosyan N, Chen EP, Ndong VN, Yao Y, Sterner CJ, Chodosh LA, Lawson JA, Fitzgerald GA, Smyth EM. Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors. Carcinogenesis. 32: 1441-9. PMID 21771729 DOI: 10.1093/Carcin/Bgr134 |
0.679 |
|
| 2011 |
Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 986-1000. PMID 21508345 DOI: 10.1161/Atvbaha.110.207449 |
0.32 |
|
| 2011 |
Wang M, Ihida-Stansbury K, Kothapalli D, Tamby MC, Yu Z, Chen L, Grant G, Cheng Y, Lawson JA, Assoian RK, Jones PL, Fitzgerald GA. Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury. Circulation. 123: 631-9. PMID 21282500 DOI: 10.1161/Circulationaha.110.973685 |
0.489 |
|
| 2011 |
Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, Onland-Moret NC, Lettre G, Ongen H, Rajagopalan R, Johnson T, Shen H, Nelson CP, Klopp N, Baumert J, Padmanabhan S, ... ... Fitzgerald GA, et al. Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. American Journal of Human Genetics. 88: 6-18. PMID 21194676 DOI: 10.1016/J.Ajhg.2010.11.007 |
0.585 |
|
| 2010 |
Wang M, FitzGerald GA. Cardiovascular biology of microsomal prostaglandin E synthase-1. Trends in Cardiovascular Medicine. 20: 189-95. PMID 22137640 DOI: 10.1016/J.Tcm.2011.04.002 |
0.307 |
|
| 2010 |
Hui Y, Ricciotti E, Crichton I, Yu Z, Wang D, Stubbe J, Wang M, Puré E, FitzGerald GA. Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation. 121: 2654-60. PMID 20530000 DOI: 10.1161/Circulationaha.109.910687 |
0.505 |
|
| 2010 |
Wang M, Cooper PR, Jiang M, Zhao H, Hui Y, Yao Y, Tate JC, Damera G, Lawson JA, Jester WF, Haczku A, Panettieri RA, FitzGerald GA. Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness. The Journal of Pharmacology and Experimental Therapeutics. 334: 63-8. PMID 20371706 DOI: 10.1124/Jpet.110.166678 |
0.304 |
|
| 2010 |
Paschos GK, Baggs JE, Hogenesch JB, FitzGerald GA. The role of clock genes in pharmacology. Annual Review of Pharmacology and Toxicology. 50: 187-214. PMID 20055702 DOI: 10.1146/Annurev.Pharmtox.010909.105621 |
0.545 |
|
| 2010 |
Yu Y, Stubbe J, Ibrahim S, Song WL, Smyth EM, Symth EM, Funk CD, FitzGerald GA. Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice. Circulation Research. 106: 337-45. PMID 19940265 DOI: 10.1161/Circresaha.109.204529 |
0.632 |
|
| 2010 |
Smyth EM, FitzGerald GA. Prostaglandin mediators Handbook of Cell Signaling, 2/E. 2: 1219-1228. DOI: 10.1016/B978-0-12-374145-5.00150-9 |
0.573 |
|
| 2009 |
Yu Y, Ricciotti E, Grosser T, Fitzgerald GA. The translational therapeutics of prostaglandin inhibition in atherothrombosis. Journal of Thrombosis and Haemostasis : Jth. 7: 222-6. PMID 19630805 DOI: 10.1111/J.1538-7836.2009.03439.X |
0.328 |
|
| 2009 |
Grad E, Golomb M, Koroukhov N, Lawson JA, Lotan C, Fitzgerald GA, Danenberg HD. Aspirin reduces the prothrombotic activity of C-reactive protein. Journal of Thrombosis and Haemostasis : Jth. 7: 1393-400. PMID 19522741 DOI: 10.1111/J.1538-7836.2009.03511.X |
0.335 |
|
| 2009 |
Yu Y, Lucitt MB, Stubbe J, Cheng Y, Friis UG, Hansen PB, Jensen BL, Smyth EM, FitzGerald GA. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 106: 7985-90. PMID 19416858 DOI: 10.1073/Pnas.0811834106 |
0.623 |
|
| 2009 |
Wang D, Patel VV, Ricciotti E, Zhou R, Levin MD, Gao E, Yu Z, Ferrari VA, Lu MM, Xu J, Zhang H, Hui Y, Cheng Y, Petrenko N, Yu Y, ... FitzGerald GA, et al. Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. Proceedings of the National Academy of Sciences of the United States of America. 106: 7548-52. PMID 19376970 DOI: 10.1073/Pnas.0805806106 |
0.482 |
|
| 2009 |
Baggs JE, Price TS, DiTacchio L, Panda S, Fitzgerald GA, Hogenesch JB. Network features of the mammalian circadian clock. Plos Biology. 7: e52. PMID 19278294 DOI: 10.1371/Journal.Pbio.1000052 |
0.696 |
|
| 2009 |
Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. Prostanoids in health and disease. Journal of Lipid Research. 50: S423-8. PMID 19095631 DOI: 10.1194/Jlr.R800094-Jlr200 |
0.603 |
|
| 2008 |
Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, Galver L, Barrett JC, Grant SF, Farlow DN, Chandrupatla HR, Hansen M, Ajmal S, Papanicolaou GJ, Guo Y, ... ... Fitzgerald GA, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. Plos One. 3: e3583. PMID 18974833 DOI: 10.1371/Journal.Pone.0003583 |
0.606 |
|
| 2008 |
Price TS, Baggs JE, Curtis AM, Fitzgerald GA, Hogenesch JB. WAVECLOCK: wavelet analysis of circadian oscillation. Bioinformatics (Oxford, England). 24: 2794-5. PMID 18931366 DOI: 10.1093/Bioinformatics/Btn521 |
0.463 |
|
| 2008 |
Chen M, Boilard E, Nigrovic PA, Clark P, Xu D, Fitzgerald GA, Audoly LP, Lee DM. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis. Arthritis and Rheumatism. 58: 1354-65. PMID 18438856 DOI: 10.1002/Art.23453 |
0.314 |
|
| 2008 |
Westgate EJ, Cheng Y, Reilly DF, Price TS, Walisser JA, Bradfield CA, FitzGerald GA. Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation. 117: 2087-95. PMID 18413500 DOI: 10.1161/Circulationaha.107.739227 |
0.624 |
|
| 2008 |
Wang M, Song WL, Cheng Y, Fitzgerald GA. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. Journal of Internal Medicine. 263: 500-5. PMID 18410593 DOI: 10.1111/J.1365-2796.2008.01938.X |
0.316 |
|
| 2008 |
Kunieda T, Minamino T, Miura K, Katsuno T, Tateno K, Miyauchi H, Kaneko S, Bradfield CA, FitzGerald GA, Komuro I. Reduced nitric oxide causes age-associated impairment of circadian rhythmicity. Circulation Research. 102: 607-14. PMID 18218984 DOI: 10.1161/Circresaha.107.162230 |
0.302 |
|
| 2008 |
Lucitt MB, Price TS, Pizarro A, Wu W, Yocum AK, Seiler C, Pack MA, Blair IA, Fitzgerald GA, Grosser T. Analysis of the zebrafish proteome during embryonic development. Molecular & Cellular Proteomics : McP. 7: 981-94. PMID 18212345 DOI: 10.1074/Mcp.M700382-Mcp200 |
0.589 |
|
| 2007 |
Funk CD, FitzGerald GA. COX-2 inhibitors and cardiovascular risk. Journal of Cardiovascular Pharmacology. 50: 470-9. PMID 18030055 DOI: 10.1097/Fjc.0B013E318157F72D |
0.328 |
|
| 2007 |
Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, Smyth EM, Wilson SJ, FitzGerald GA, Garavito RM, Sui de X, et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. The Journal of Biological Chemistry. 282: 22254-66. PMID 17519235 DOI: 10.1074/Jbc.M703169200 |
0.613 |
|
| 2007 |
Curtis AM, Cheng Y, Kapoor S, Reilly D, Price TS, Fitzgerald GA. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proceedings of the National Academy of Sciences of the United States of America. 104: 3450-5. PMID 17360665 DOI: 10.1073/Pnas.0611680104 |
0.621 |
|
| 2007 |
Price TS, Lucitt MB, Wu W, Austin DJ, Pizarro A, Yocum AK, Blair IA, FitzGerald GA, Grosser T. EBP, a program for protein identification using multiple tandem mass spectrometry datasets. Molecular & Cellular Proteomics : McP. 6: 527-36. PMID 17164401 DOI: 10.1074/Mcp.T600049-Mcp200 |
0.582 |
|
| 2007 |
Yu Y, Fan J, Hui Y, Rouzer CA, Marnett LJ, Klein-Szanto AJ, FitzGerald GA, Funk CD. Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality. The Journal of Biological Chemistry. 282: 1498-506. PMID 17110378 DOI: 10.1074/Jbc.M609930200 |
0.332 |
|
| 2006 |
Egan K, FitzGerald GA. Eicosanoids and the vascular endothelium. Handbook of Experimental Pharmacology. 189-211. PMID 16999220 DOI: 10.1007/3-540-32967-6_6 |
0.337 |
|
| 2006 |
Wang M, Zukas AM, Hui Y, Ricciotti E, Puré E, FitzGerald GA. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proceedings of the National Academy of Sciences of the United States of America. 103: 14507-12. PMID 16973753 DOI: 10.1073/Pnas.0606586103 |
0.327 |
|
| 2006 |
Yu Y, Fan J, Chen XS, Wang D, Klein-Szanto AJ, Campbell RL, FitzGerald GA, Funk CD. Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. Nature Medicine. 12: 699-704. PMID 16732282 DOI: 10.1038/Nm1412 |
0.33 |
|
| 2006 |
Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, Fitzgerald GA. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. The Journal of Clinical Investigation. 116: 1391-9. PMID 16614756 DOI: 10.1172/Jci27540 |
0.346 |
|
| 2006 |
Lovgren AK, Jania LA, Hartney JM, Parsons KK, Audoly LP, Fitzgerald GA, Tilley SL, Koller BH. COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology. 291: L144-56. PMID 16473862 DOI: 10.1152/Ajplung.00492.2005 |
0.313 |
|
| 2006 |
Fries S, Grosser T, Price TS, Lawson JA, Kapoor S, DeMarco S, Pletcher MT, Wiltshire T, FitzGerald GA. Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2. Gastroenterology. 130: 55-64. PMID 16401468 DOI: 10.1053/J.Gastro.2005.10.002 |
0.619 |
|
| 2006 |
Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. The Journal of Clinical Investigation. 116: 4-15. PMID 16395396 DOI: 10.1172/Jci27291 |
0.326 |
|
| 2005 |
Rudic RD, McNamara P, Reilly D, Grosser T, Curtis AM, Price TS, Panda S, Hogenesch JB, FitzGerald GA. Bioinformatic analysis of circadian gene oscillation in mouse aorta. Circulation. 112: 2716-24. PMID 16230482 DOI: 10.1161/Circulationaha.105.568626 |
0.7 |
|
| 2005 |
Francois H, Athirakul K, Howell D, Dash R, Mao L, Kim HS, Rockman HA, Fitzgerald GA, Koller BH, Coffman TM. Prostacyclin protects against elevated blood pressure and cardiac fibrosis. Cell Metabolism. 2: 201-7. PMID 16154102 DOI: 10.1016/J.Cmet.2005.08.005 |
0.316 |
|
| 2005 |
Rudic RD, Brinster D, Cheng Y, Fries S, Song WL, Austin S, Coffman TM, FitzGerald GA. COX-2-derived prostacyclin modulates vascular remodeling. Circulation Research. 96: 1240-7. PMID 15905461 DOI: 10.1161/01.Res.0000170888.11669.28 |
0.331 |
|
| 2005 |
Wang D, Wong D, Wang M, Cheng Y, Fitzgerald GA. Cardiovascular hazard and non-steroidal anti-inflammatory drugs. Current Opinion in Pharmacology. 5: 204-10. PMID 15780832 DOI: 10.1016/J.Coph.2005.02.001 |
0.352 |
|
| 2005 |
Yu Y, Cheng Y, Fan J, Chen XS, Klein-Szanto A, Fitzgerald GA, Funk CD. Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition. The Journal of Clinical Investigation. 115: 986-95. PMID 15776109 DOI: 10.1172/Jci23683 |
0.332 |
|
| 2005 |
Pini B, Grosser T, Lawson JA, Price TS, Pack MA, FitzGerald GA. Prostaglandin E synthases in zebrafish. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 315-20. PMID 15576635 DOI: 10.1161/01.Atv.0000152355.97808.10 |
0.62 |
|
| 2005 |
Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM, FitzGerald GA. Cyclooxygenase-2-Derived Prostacyclin Confers Atheroprotection on Female Mice Obstetrical & Gynecological Survey. 60: 309-310. DOI: 10.1097/01.Ogx.0000160574.33752.4F |
0.64 |
|
| 2004 |
Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM, Fitzgerald GA. COX-2-derived prostacyclin confers atheroprotection on female mice. Science (New York, N.Y.). 306: 1954-7. PMID 15550624 DOI: 10.1126/Science.1103333 |
0.618 |
|
| 2004 |
Hui Y, Cheng Y, Smalera I, Jian W, Goldhahn L, Fitzgerald GA, Funk CD. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation. 110: 3360-6. PMID 15545522 DOI: 10.1161/01.Cir.0000147775.50954.Aa |
0.316 |
|
| 2004 |
Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S, Hogenesch JB, Fitzgerald GA. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. Plos Biology. 2: e377. PMID 15523558 DOI: 10.1371/Journal.Pbio.0020377 |
0.523 |
|
| 2004 |
Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 126: 234S-264S. PMID 15383474 DOI: 10.1378/Chest.126.3_Suppl.234S |
0.304 |
|
| 2004 |
Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, FitzGerald GA, Kay SA, Hogenesch JB. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron. 43: 527-37. PMID 15312651 DOI: 10.1016/J.Neuron.2004.07.018 |
0.545 |
|
| 2004 |
Curtis AM, Seo SB, Westgate EJ, Rudic RD, Smyth EM, Chakravarti D, FitzGerald GA, McNamara P. Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. The Journal of Biological Chemistry. 279: 7091-7. PMID 14645221 DOI: 10.1074/Jbc.M311973200 |
0.603 |
|
| 2003 |
FitzGerald GA. COX-2 and beyond: Approaches to prostaglandin inhibition in human disease. Nature Reviews. Drug Discovery. 2: 879-90. PMID 14668809 DOI: 10.1038/Nrd1225 |
0.306 |
|
| 2003 |
Zhang Z, Vezza R, Plappert T, McNamara P, Lawson JA, Austin S, Praticò D, Sutton MS, FitzGerald GA. COX-2-dependent cardiac failure in Gh/tTG transgenic mice. Circulation Research. 92: 1153-61. PMID 12702643 DOI: 10.1161/01.Res.0000071749.22027.45 |
0.312 |
|
| 2002 |
Smyth EM, Austin SC, FitzGerald GA. Activation-dependent internalization of the human prostacyclin receptor. Advances in Experimental Medicine and Biology. 507: 295-301. PMID 12664600 DOI: 10.1007/978-1-4615-0193-0_45 |
0.594 |
|
| 2002 |
Smyth EM, FitzGerald GA. Human prostacyclin receptor. Vitamins and Hormones. 65: 149-65. PMID 12481546 DOI: 10.1016/S0083-6729(02)65063-0 |
0.615 |
|
| 2002 |
FitzGerald GA. The choreography of cyclooxygenases in the kidney. The Journal of Clinical Investigation. 110: 33-4. PMID 12093885 DOI: 10.1172/Jci16044 |
0.301 |
|
| 2002 |
Grosser T, Yusuff S, Cheskis E, Pack MA, FitzGerald GA. Developmental expression of functional cyclooxygenases in zebrafish. Proceedings of the National Academy of Sciences of the United States of America. 99: 8418-23. PMID 12011329 DOI: 10.1073/Pnas.112217799 |
0.31 |
|
| 2002 |
Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science (New York, N.Y.). 296: 539-41. PMID 11964481 DOI: 10.1126/Science.1068711 |
0.345 |
|
| 2002 |
FitzGerald GA. Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations. The American Journal of Cardiology. 89: 26D-32D. PMID 11909558 DOI: 10.1016/S0002-9149(02)02234-8 |
0.338 |
|
| 2002 |
Reilly M, FitzGerald GA. Gathering intelligence on antiplatelet drugs: the view from 30 000 feet. When combined with other information overviews lead to conviction. Bmj (Clinical Research Ed.). 324: 59-60. PMID 11786434 DOI: 10.1136/Bmj.324.7329.59 |
0.3 |
|
| 2001 |
Catella-Lawson F, Kapoor S, Moretti D, De Marco S, Vigilante GJ, Cucchiara AJ, Ramsey KE, Combe S, Rocca B, Theroux P, FitzGerald GA. Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease. The American Journal of Cardiology. 88: 236-42. PMID 11472700 DOI: 10.1016/S0002-9149(01)01632-0 |
0.31 |
|
| 2001 |
McNamara P, Seo SB, Rudic RD, Sehgal A, Chakravarti D, FitzGerald GA. Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell. 105: 877-89. PMID 11439184 DOI: 10.1016/S0092-8674(01)00401-9 |
0.302 |
|
| 2001 |
Praticò D, Tillmann C, Zhang ZB, Li H, FitzGerald GA. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 3358-63. PMID 11248083 DOI: 10.1073/Pnas.061607398 |
0.369 |
|
| 2001 |
Fabre JE, Nguyen M, Athirakul K, Coggins K, McNeish JD, Austin S, Parise LK, FitzGerald GA, Coffman TM, Koller BH. Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. The Journal of Clinical Investigation. 107: 603-10. PMID 11238561 DOI: 10.1172/Jci10881 |
0.32 |
|
| 2001 |
Whitehead AS, FitzGerald GA. Twenty-first century phox: not yet ready for widespread screening. Circulation. 103: 7-9. PMID 11136676 DOI: 10.1161/01.Cir.103.1.7 |
0.305 |
|
| 2000 |
Praticò D, Cyrus T, Li H, FitzGerald GA. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis. Blood. 96: 3823-6. PMID 11090066 DOI: 10.1182/Blood.V96.12.3823.H8003823_3823_3826 |
0.322 |
|
| 2000 |
Praticó D, Cheng Y, FitzGerald GA. TP or not TP: primary mediators in a close runoff? Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1695-8. PMID 10894803 DOI: 10.1161/01.Atv.20.7.1695 |
0.323 |
|
| 2000 |
Smyth EM, Austin SC, Reilly MP, FitzGerald GA. Internalization and sequestration of the human prostacyclin receptor. The Journal of Biological Chemistry. 275: 32037-45. PMID 10889200 DOI: 10.1074/Jbc.M003873200 |
0.618 |
|
| 2000 |
Audoly LP, Rocca B, Fabre JE, Koller BH, Thomas D, Loeb AL, Coffman TM, FitzGerald GA. Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation. 101: 2833-40. PMID 10859290 DOI: 10.1161/01.Cir.101.24.2833 |
0.303 |
|
| 1999 |
Austin S, FitzGerald GA. Not a mouse stirring: deletion of the EP2 and love's labor's lost. The Journal of Clinical Investigation. 103: 1481-2. PMID 10359555 DOI: 10.1172/Jci7289 |
0.326 |
|
| 1999 |
Habib A, FitzGerald GA, Maclouf J. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. The Journal of Biological Chemistry. 274: 2645-51. PMID 9915793 DOI: 10.1074/Jbc.274.5.2645 |
0.308 |
|
| 1999 |
McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proceedings of the National Academy of Sciences of the United States of America. 96: 272-7. PMID 9874808 DOI: 10.1073/Pnas.96.1.272 |
0.324 |
|
| 1998 |
Smyth EM, Li WH, FitzGerald GA. Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase c. The Journal of Biological Chemistry. 273: 23258-66. PMID 9722557 DOI: 10.1074/Jbc.273.36.23258 |
0.596 |
|
| 1998 |
Barry OP, Praticò D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. The Journal of Clinical Investigation. 102: 136-44. PMID 9649567 DOI: 10.1172/Jci2592 |
0.312 |
|
| 1998 |
Praticò D, Barry OP, Lawson JA, Adiyaman M, Hwang SW, Khanapure SP, Iuliano L, Rokach J, FitzGerald GA. IPF2alpha-I: an index of lipid peroxidation in humans. Proceedings of the National Academy of Sciences of the United States of America. 95: 3449-54. PMID 9520386 DOI: 10.1073/Pnas.95.7.3449 |
0.307 |
|
| 1998 |
Reilly MP, Lawson JA, FitzGerald GA. Eicosanoids and isoeicosanoids: indices of cellular function and oxidant stress. The Journal of Nutrition. 128: 434S-438S. PMID 9478043 DOI: 10.1093/Jn/128.2.434S |
0.317 |
|
| 1997 |
Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 2309-15. PMID 9409197 DOI: 10.1161/01.Atv.17.11.2309 |
0.313 |
|
| 1997 |
FitzGerald GA, Tigges J, Barry P, Lawson JA. Markers of platelet activation and oxidant stress in atherothrombotic disease. Thrombosis and Haemostasis. 78: 280-4. PMID 9198167 DOI: 10.1055/S-0038-1657540 |
0.306 |
|
| 1997 |
Catella-Lawson F, FitzGerald GA. Confusion in reperfusion. Problems in the clinical development of antithrombotic drugs. Circulation. 95: 793-5. PMID 9054731 DOI: 10.1161/01.Cir.95.4.793 |
0.325 |
|
| 1997 |
Rocca B, FitzGerald GA. Simply read: erythrocytes modulate platelet function. Should we rethink the way we give aspirin? Circulation. 95: 11-3. PMID 8994408 DOI: 10.1161/01.Cir.95.1.11 |
0.31 |
|
| 1996 |
Smyth EM, Nestor PV, FitzGerald GA. Agonist-dependent phosphorylation of an epitope-tagged human prostacyclin receptor. The Journal of Biological Chemistry. 271: 33698-704. PMID 8969241 DOI: 10.1074/Jbc.271.52.33698 |
0.606 |
|
| 1996 |
Praticò D, Smyth EM, Violi F, FitzGerald GA. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms. The Journal of Biological Chemistry. 271: 14916-24. PMID 8663015 DOI: 10.1074/Jbc.271.25.14916 |
0.627 |
|
| 1994 |
FitzGerald GA, Shipp E. Antiplatelet and anticoagulant drugs in coronary vascular disease. Annals of Epidemiology. 2: 529-42. PMID 1342304 DOI: 10.1016/1047-2797(92)90103-W |
0.325 |
|
| 1991 |
Clarke RJ, Mayo G, FitzGerald GA, Fitzgerald DJ. Combined administration of aspirin and a specific thrombin inhibitor in man. Circulation. 83: 1510-8. PMID 2022012 DOI: 10.1161/01.Cir.83.5.1510 |
0.302 |
|
| 1991 |
FitzGerald GA. Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists The American Journal of Cardiology. 68. PMID 1892057 DOI: 10.1016/0002-9149(91)90379-Y |
0.329 |
|
| 1991 |
Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment The Faseb Journal. 5: 2304-2312. DOI: 10.1096/Fasebj.5.9.1907252 |
0.315 |
|
| 1990 |
Sebaldt RJ, Sheller JR, Oates JA, Roberts LJ, FitzGerald GA. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proceedings of the National Academy of Sciences of the United States of America. 87: 6974-8. PMID 2169616 DOI: 10.1073/Pnas.87.18.6974 |
0.316 |
|
| 1989 |
Fitzgerald GA, Braden G, Fitzgerald DJ, Knapp HR. Fish oils in cardiovascular disease Journal of Internal Medicine. 225: 25-29. PMID 2650696 DOI: 10.1111/J.1365-2796.1989.Tb01432.X |
0.313 |
|
| 1989 |
Nowak J, FitzGerald GA. Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. The Journal of Clinical Investigation. 83: 380-5. PMID 2643628 DOI: 10.1172/Jci113895 |
0.322 |
|
| 1989 |
Murray R, FitzGerald GA. Regulation of thromboxane receptor activation in human platelets. Proceedings of the National Academy of Sciences of the United States of America. 86: 124-8. PMID 2521385 DOI: 10.1073/Pnas.86.1.124 |
0.303 |
|
| 1989 |
Lupinetti MD, Sheller JR, Catella F, Fitzgerald GA. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. The American Review of Respiratory Disease. 140: 932-5. PMID 2508524 DOI: 10.1164/Ajrccm/140.4.932 |
0.303 |
|
| 1989 |
Fitzgerald DJ, Wright F, FitzGerald GA. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo. Circulation Research. 65: 83-94. PMID 2500270 DOI: 10.1161/01.Res.65.1.83 |
0.302 |
|
| 1988 |
Catella F, FitzGerald GA. Paired analysis of urinary thromboxane B2 metabolites in humans. Thrombosis Research. 47: 647-56. PMID 3686481 DOI: 10.1016/0049-3848(87)90103-4 |
0.313 |
|
| 1988 |
Fitzgerald DJ, Fragetta J, FitzGerald GA. Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. The Journal of Clinical Investigation. 82: 1708-13. PMID 3183064 DOI: 10.1172/Jci113784 |
0.339 |
|
| 1987 |
Fitzgerald GA, Catella F, Oates JA. Eicosanoid biosynthesis in human cardiovascular disease. Human Pathology. 18: 248-52. PMID 3546074 DOI: 10.1016/S0046-8177(87)80007-2 |
0.327 |
|
| 1986 |
FitzGerald GA, Reilly IA, Pedersen AK. The biochemical pharmacology of thromboxane synthase inhibition in man. Circulation. 72: 1194-201. PMID 3905048 DOI: 10.1161/01.Cir.72.6.1194 |
0.323 |
|
| 1986 |
Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. The New England Journal of Medicine. 315: 983-9. PMID 3531859 DOI: 10.1056/Nejm198610163151602 |
0.303 |
|
| 1986 |
Fitzgerald DJ, Doran J, Jackson E, FitzGerald GA. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. The Journal of Clinical Investigation. 77: 496-502. PMID 3003161 DOI: 10.1172/Jci112329 |
0.31 |
|
| 1986 |
Reilly IA, Doran JB, Smith B, FitzGerald GA. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation. 73: 1300-9. PMID 2938849 DOI: 10.1161/01.Cir.73.6.1300 |
0.335 |
|
| 1985 |
Pedersen AK, FitzGerald GA. Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. Clinical Pharmacology and Therapeutics. 37: 36-42. PMID 3917387 DOI: 10.1038/Clpt.1985.8 |
0.309 |
|
| 1984 |
FitzGerald GA, Oates JA. Selective and nonselective inhibition of thromboxane formation. Clinical Pharmacology and Therapeutics. 35: 633-40. PMID 6370554 DOI: 10.1038/Clpt.1984.87 |
0.327 |
|
| 1984 |
FitzGerald GA, Smith B, Pedersen AK, Brash AR. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. The New England Journal of Medicine. 310: 1065-8. PMID 6231483 DOI: 10.1056/Nejm198404263101701 |
0.324 |
|
| 1983 |
FitzGerald GA, Brash AR, Oates JA, Pedersen AK. Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. The Journal of Clinical Investigation. 72: 1336-43. PMID 6355181 DOI: 10.1172/Jci111089 |
0.308 |
|
| Show low-probability matches. |